(Q33497917)

27 July 2017

title

Iloprost in the treatment of thrombotic microangiopathy: report of thirteen cases (English)

1 reference

27 July 2017

Sagripanti A

1 reference

27 July 2017

Carpi A

1 reference

27 July 2017

Rosaia B

1 reference

27 July 2017

Morelli E

1 reference

27 July 2017

Innocenti M

1 reference

27 July 2017

D'Acunto G

1 reference

27 July 2017

Nicolini A

1 reference

27 July 2017

publication date

1 January 1996

1 reference

Biomedicine and Pharmacotherapy

27 July 2017

published in

1 reference

27 July 2017

1 reference

27 July 2017

1 reference

27 July 2017

page(s)

350-356

1 reference

THROMBOTIC THROMBOCYTOPENIC PURPURA

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2896%2989667-3

7 January 2021

Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2896%2989667-3

7 January 2021

Prostacyclin therapy of thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2896%2989667-3

7 January 2021

Accelerated prostacyclin degradation in the thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2896%2989667-3

7 January 2021

Trial of iloprost versus aspirin treatment for critical limb ischaemia of thromboangiitis obliterans. The TAO Study

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2896%2989667-3

7 January 2021

Intravenous prostacyclin in thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2896%2989667-3

7 January 2021

Prostacyclin deficiency in thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2896%2989667-3

7 January 2021

Human β-thromboglobulin inhibits PGI2 production and binds to a specific site in bovine aortic endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2896%2989667-3

7 January 2021

Early manifestation of thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2896%2989667-3

7 January 2021

Inhibitor of prostacyclin production in sporadic haemolytic uraemic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2896%2989667-3

7 January 2021

Plasma 6-keto-PGF1 alpha levels after plasma exchange in thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2896%2989667-3

7 January 2021

Bias due to publication of positive results with treatments for thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2896%2989667-3

7 January 2021

Renal prostacyclin biosynthesis is reduced in children with hemolytic-uremic syndrome in the context of systemic platelet activation

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2896%2989667-3

7 January 2021

SUCCESSFUL TREATMENT OF THROMBOTIC THROMBOCYTOPENIC PURPURA BY EPOPROSTENOL INFUSION

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2896%2989667-3

7 January 2021

Treatment of thrombotic thrombocytopenic purpura. Evaluation of plasma exchange and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2896%2989667-3

7 January 2021

Haemolytic-uraemic syndrome: deficiency of plasma factor(s) regulating prostacyclin activity?

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2896%2989667-3

7 January 2021

The hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2896%2989667-3

7 January 2021

Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2896%2989667-3

7 January 2021

High incidence of relapses in thrombotic thrombocytopenic purpura. Clinical study of 38 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2896%2989667-3

7 January 2021

Quantitation of serum prostacyclin-binding in thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2896%2989667-3

7 January 2021

Inherited plasma factor deficiency in haemolytic-uraemic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2896%2989667-3

7 January 2021

Prostacyclin deficiency in haemolytic-uraemic syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2896%2989667-3

7 January 2021

Serum prostacyclin binding defects in thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2896%2989667-3

7 January 2021

10.1016/S0753-3322(96)89667-3

Identifiers

DOI

1 reference

27 July 2017

1 reference